Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
International Journal of Environmental Research and Public Health April 17, 2018 Carola Rong, Caroline Park, Joshua D. Rosenblat et al. 116 citations
OBJECTIVES: Extant evidence indicates that ketamine exerts rapid antidepressant effects in treatment-resistant depressive (TRD) symptoms as a part of major depressive disorder (MDD) and bipolar disorder (BD). The identification of depressed sub-populations that are more likely to benefit from ketamine treatment remains a priority. In keeping with this view, the present narrative review aims to...